| Structural characterization of a novel GPVI-nanobody complex reveals a biologically active domain-swapped GPVI dimer A Slater, Y Di, JC Clark, NJ Jooss, EM Martin, F Alenazy, MR Thomas, ... Blood, The Journal of the American Society of Hematology 137 (24), 3443-3453, 2021 | 29 | 2021 |
| Novel antiplatelet targets in the treatment of acute coronary syndromes FO Alenazy, MR Thomas Platelets 32 (1), 15-28, 2021 | 23 | 2021 |
| The role of vitamin D in reducing the risk of metabolic disturbances that cause cardiovascular diseases ZH Al-Oanzi, FO Alenazy, HH Alhassan, Y Alruwaili, AI Alessa, NB Alfarm, ... Journal of Cardiovascular Development and Disease 10 (5), 209, 2023 | 10 | 2023 |
| Antithrombotic effects of fostamatinib in combination with conventional antiplatelet drugs MH Harbi, CW Smith, FO Alenazy, PLR Nicolson, A Tiwari, SP Watson, ... International Journal of Molecular Sciences 23 (13), 6982, 2022 | 9 | 2022 |
| Insight into oncogenic viral pathways as drivers of viral cancers: implication for effective therapy AME Elkhalifa, SU Nabi, OS Shah, SM Bashir, U Muzaffer, SI Ali, IA Wani, ... Current Oncology 30 (2), 1924-1944, 2023 | 8 | 2023 |
| IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia EK Abdalhabib, B Alzahrani, M Saboor, A Hamza, EM Elfaki, F Alanazi, ... Pharmacogenomics and Personalized Medicine, 809-815, 2022 | 6 | 2022 |
| GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy FO Alenazy, MH Harbi, DP Kavanagh, J Price, P Brady, O Hargreaves, ... European Heart Journal 42 (Supplement_1), ehab724. 1425, 2021 | 6 | 2021 |
| Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy FO Alenazy, MH Harbi, DP Kavanagh, J Price, P Brady, O Hargreaves, ... Journal of Thrombosis and Haemostasis 21 (11), 3236-3251, 2023 | 4 | 2023 |
| SMIFH2 inhibition of platelets demonstrates a critical role for formin proteins in platelet cytoskeletal dynamics HLH Green, M Zuidscherwoude, F Alenazy, CW Smith, M Bender, ... Journal of Thrombosis and Haemostasis 18 (4), 955-967, 2020 | 4 | 2020 |
| Effects of Thymoquinone Alone or in Combination with Losartan on the Cardiotoxicity Caused by Oxidative Stress and Inflammation in Hypercholesterolemia ZH Al-Oanzi, FO Alenazy, HH Alhassan, MR El-Aassar, AI Alzarea, ... Journal of Cardiovascular Development and Disease 9 (12), 428, 2022 | 3 | 2022 |
| Impact of methionine synthase reductase polymorphisms in chronic myeloid leukemia patients AY Elderdery, EM Tebein, FO Alenazy, AME Elkhalifa, MG Shalabi, ... Genes 13 (10), 1729, 2022 | 3 | 2022 |
| Clinical Characterization and Outcomes of Patients with Hypercreatinemia Affected by COVID-19 AME Elkhalifa, NN Shah, Z Khan, SI Ali, SU Nabi, SM Bashir, MS Mir, ... Healthcare 11 (7), 944, 2023 | 1 | 2023 |
| The critical impacts of cytokine storms in respiratory disorders SR Tramboo, AME Elkhalifa, S Quibtiya, SI Ali, NN Shah, S Taifa, ... Heliyon 10 (9), 2024 | | 2024 |
| Enhanced apoptotic activity of Pluronic F127 polymer-encapsulated chlorogenic acid nanoparticles through the PI3K/Akt/mTOR signaling pathway in liver cancer cells and in vivo … F Alanazi, AY Elderdery, B Alzahrani, NAN Alzerwi, MM Althobiti, ... e-Polymers 23 (1), 20230053, 2023 | | 2023 |
| GC-MS-based profiling and ameliorative potential of Carissa opaca Stapf ex Haines fruit against cardiac and testicular toxicity: An In vivo study HH Alhassan, LA Al-Keridis, H Ayub, FO Alenazy, Y Alruwaili, MR Khan, ... Heliyon 9 (8), 2023 | | 2023 |
| Thrombocytopenia Induced in Mice by Intraperitoneal Administration of Gold and Iron Oxide Nanoparticles H Almarshad, A Elderdery, F Alenazy, K Shalaby, I Hamad, O Hendawy INTERNATIONAL JOURNAL OF PHARMACOLOGY 19 (6), 2023 | | 2023 |
| Inhibition of the platelet glycoprotein VI receptor as a potential treatment for acute coronary syndromes FOM Alenazy University of Birmingham, 2021 | | 2021 |
